Takeda's Hasegawa Declares Big-Acquisition Days Over For Global Players
This article was originally published in PharmAsia News
Executive Summary
Takeda Pharmaceutical's outgoing President Yasuchika Hasegawa said the days of large deals as a way to expand in the global drug market are over, but suggested smaller bolt-on acquisitions are possible in certain areas.